Intevac Announces Third Quarter 2017 Financial Results
Mon, October 30 2017
Third Quarter Highlights
- Revenue and earnings exceeding guidance, primarily due to pull-ins of technology upgrades in our core HDD (hard disk drive) business;
- Revenues recognized on two 200 Lean® HDD systems; two additional 200 Leans booked for delivery in 2018, bringing 200 Lean backlog to five systems at quarter end; and
- Improved performance for Photonics, with new orders, revenues, gross margin and operating margin each increasing quarter-over-quarter.
Commenting on the third quarter, President and CEO
($ Millions, except per share amounts) | Q3 2017 | Q3 2016 | |||||||||||||
GAAP Results | Non-GAAP Results | GAAP Results | Non-GAAP Results | ||||||||||||
Net Revenues | $ | 26.7 | $ | 26.7 | $ | 22.6 | $ | 22.6 | |||||||
Operating Income (Loss) | $ | 1.3 | $ | 1.0 | $ | (0.3 | ) | $ | (0.3 | ) | |||||
Net Income (Loss) | $ | 1.2 | $ | 0.9 | $ | (0.5 | ) | $ | (0.4 | ) | |||||
Net Income (Loss) per Share | $ | 0.05 | $ | 0.04 | $ | (0.02 | ) | $ | (0.02 | ) | |||||
|
Nine Months Ended | Nine Months Ended | |||||||||||||
|
|
||||||||||||||
GAAP Results | Non-GAAP Results | GAAP Results | Non-GAAP Results | ||||||||||||
Net Revenues | $ | 88.1 | $ | 88.1 | $ | 51.1 | $ | 51.1 | |||||||
Operating Income (Loss) | $ | 4.7 | $ | 4.5 | $ | (10.4 | ) | $ | (10.5 | ) | |||||
Net Income (Loss) | $ | 4.2 | $ | 4.0 | $ | (10.3 | ) | $ | (10.4 | ) | |||||
Net Income (Loss) per Share | $ | 0.18 | $ | 0.17 | $ | (0.50 | ) | $ | (0.50 | ) | |||||
Intevac’s non-GAAP adjusted results exclude the impact of changes in fair value of contingent consideration liabilities associated with business combinations. A reconciliation of the GAAP and non-GAAP adjusted results is provided in the financial table included in this release. See also “Use of Non-GAAP Financial Measures” section.
Third Quarter 2017 Summary
Net income for the quarter was
Revenues were
Thin-film Equipment gross margin was 45.5% compared to 32.4% in the third quarter of 2016 and 38.4% in the second quarter of 2017. The improvement from the third quarter of 2016 reflected a higher level of revenue and improved factory absorption. The improvement from the second quarter of 2017 reflected higher margins on systems shipments, offset in part by higher inventory provisions. Thin-film Equipment gross margin in the second quarter of 2017 reflected the lower margin on a pilot MATRIX ion implant system for solar panels.
Photonics gross margin was 36.5% compared to 46.9% in the third quarter of 2016 and 33.4% in the second quarter of 2017. The decrease from the third quarter of 2016 was due to lower margins on research and development contracts and higher inventory provisions. The improvement from the second quarter of 2017 was due to improved sensor yields and higher margins on research and development contracts, offset in part by higher inventory provisions. Consolidated gross margin was 42.3%, compared to 37.7% in the third quarter of 2016 and 37.0% in the second quarter of 2017.
R&D and SG&A expenses were
Order backlog totaled
The Company ended the quarter with
First Nine Months 2017 Summary
Net income was
Revenues were
Thin-film Equipment gross margin was 42.0%, compared to 28.3% in the first nine months of 2016. The improvement reflected a higher level of revenue and improved factory absorption. Photonics gross margin was 37.5% compared to 44.3% in the first nine months of 2016, reflecting lower margins on research and development contracts and higher inventory provisions. Consolidated gross margin was 40.7%, compared to 36.2% in the first nine months of 2016.
R&D and SG&A expenses were
Use of Non-GAAP Financial Measures
Management uses non-GAAP results to evaluate the company’s operating and
financial performance in light of business objectives and for planning
purposes. These measures are not in accordance with GAAP and may differ
from non-GAAP methods of accounting and reporting used by other
companies.
Conference Call Information
The Company will discuss its financial results and outlook in a conference call today at 1:30 p.m. PDT (4:30 p.m. EDT). To participate in the teleconference, please call toll-free (877) 334-0811 prior to the start time. For international callers, the dial-in number is (408) 427-3734. You may also listen live via the Internet at the Company's website, www.intevac.com, under the Investors link, or at www.earnings.com. For those unable to attend, these web sites will host an archive of the call. Additionally, a telephone replay of the call will be available for 48 hours beginning today at 7:30 p.m. EDT. You may access the replay by calling (855) 859-2056 or, for international callers, (404) 537-3406, and providing Replay Passcode 86944119.
About
In our Thin-film Equipment business, we are a leader in the design and development of high-productivity, thin-film processing systems. Our production-proven platforms are designed for high-volume manufacturing of substrates with precise thin film properties, such as the hard drive media, display cover panel, and solar photovoltaic markets we serve currently.
In our Photonics business, we are a recognized leading developer of
advanced high-sensitivity digital sensors, cameras and systems that
primarily serve the defense industry. We are the provider of integrated
digital imaging systems for most
For more information call 408-986-9888, or visit the Company's website at www.intevac.com.
200 Lean® is a registered trademark and
Safe Harbor Statement
This press release includes statements that constitute “forward-looking
statements” within the meaning of the Private Securities Litigation
Reform Act of 1995 (the “Reform Act”).
|
|||||||||||||||||
Three months ended | Nine months ended | ||||||||||||||||
|
|
|
|
||||||||||||||
Net revenues | |||||||||||||||||
Thin-film Equipment | $ | 17,177 | $ | 14,272 | $ | 61,087 | $ | 25,941 | |||||||||
Photonics | 9,549 | 8,287 | 26,990 | 25,201 | |||||||||||||
Total net revenues | 26,726 | 22,559 | 88,077 | 51,142 | |||||||||||||
Gross profit | 11,298 | 8,515 | 35,816 | 18,497 | |||||||||||||
Gross margin | |||||||||||||||||
Thin-film Equipment | 45.5 | % | 32.4 | % | 42.0 | % | 28.3 | % | |||||||||
Photonics | 36.5 | % | 46.9 | % | 37.5 | % | 44.3 | % | |||||||||
Consolidated | 42.3 | % | 37.7 | % | 40.7 | % | 36.2 | % | |||||||||
Operating expenses | |||||||||||||||||
Research and development | 4,535 | 4,067 | 13,635 | 14,220 | |||||||||||||
Selling, general and administrative | 5,778 | 4,720 | 17,663 | 14,814 | |||||||||||||
Acquisition-related1 | (283 | ) | 52 | (181 | ) | (90 | ) | ||||||||||
Total operating expenses | 10,030 | 8,839 | 31,117 | 28,944 | |||||||||||||
Total operating income (loss) | 1,268 | (324 | ) | 4,699 | (10,447 | ) | |||||||||||
Operating income (loss) | |||||||||||||||||
Thin-film Equipment | 1,213 | (998 | ) | 4,821 | (10,117 | ) | |||||||||||
Photonics | 1,417 | 1,737 | 3,646 | 3,656 | |||||||||||||
Corporate | (1,362 | ) | (1,063 | ) | (3,768 | ) | (3,986 | ) | |||||||||
Total operating income (loss) | 1,268 | (324 | ) | 4,699 | (10,447 | ) | |||||||||||
Interest income and other income (expense), net | 28 | 60 | 265 | 184 | |||||||||||||
Net income (loss) before income taxes | 1,296 | (264 | ) | 4,964 | (10,263 | ) | |||||||||||
Provision for income taxes | 66 | 217 | 805 | 13 | |||||||||||||
Net income (loss) | $ | 1,230 | $ | (481 | ) | $ | 4,159 | $ | (10,276 | ) | |||||||
Net income (loss) per share | |||||||||||||||||
Basic | $ | 0.06 | $ | (0.02 | ) | $ | 0.19 | $ | (0.50 | ) | |||||||
Diluted | $ | 0.05 | $ | (0.02 | ) | $ | 0.18 | $ | (0.50 | ) | |||||||
Weighted average common shares outstanding | |||||||||||||||||
Basic | 21,714 | 20,869 | 21,475 | 20,704 | |||||||||||||
Diluted | 22,970 | 20,869 | 22,989 | 20,704 |
1Results for all periods presented include changes in fair value of contingent consideration obligations associated with the Solar Implant Technology (SIT) acquisition in 2010.
|
|||||||||
|
|
||||||||
(Unaudited) | (see Note) | ||||||||
ASSETS | |||||||||
Current assets | |||||||||
Cash, cash equivalents and short-term investments | $ | 37,234 |
|
||||||
Accounts receivable, net | 22,311 | 17,447 | |||||||
Inventories | 32,581 | 24,876 | |||||||
Prepaid expenses and other current assets | 2,825 | 1,768 | |||||||
Total current assets | 94,951 | 88,736 | |||||||
Long-term investments | 6,165 | 3,593 | |||||||
Restricted cash | 1,400 | 1,602 | |||||||
Property, plant and equipment, net | 12,509 | 11,237 | |||||||
Intangible assets, net | 1,662 | 2,258 | |||||||
Other long-term assets | 745 | 898 | |||||||
Total assets | $ | 117,432 |
|
||||||
LIABILITIES AND STOCKHOLDERS’ EQUITY | |||||||||
Current liabilities | |||||||||
Accounts payable | $ | 7,036 |
|
||||||
Accrued payroll and related liabilities | 5,781 |
|
4,220 |
||||||
Other accrued liabilities | 7,856 | 17,011 | |||||||
Customer advances | 12,347 | 5,422 | |||||||
Total current liabilities | 33,020 | 31,976 | |||||||
Other long-term liabilities | 2,994 | 3,082 | |||||||
Stockholders’ equity | |||||||||
Common stock ( |
22 | 21 | |||||||
Additional paid-in capital | 176,282 | 171,314 | |||||||
|
(28,489 | ) | (28,489 | ) | |||||
Accumulated other comprehensive income | 443 | 321 | |||||||
Accumulated deficit | (66,840 | ) | (69,901 | ) | |||||
Total stockholders’ equity | 81,418 | 73,266 | |||||||
Total liabilities and stockholders’ equity | $ | 117,432 |
|
Note: Amounts as of
|
|||||||||||||||||
|
|||||||||||||||||
Three months ended |
|
Nine months ended |
|||||||||||||||
|
|
|
|
||||||||||||||
Non-GAAP Income (Loss) from Operations | |||||||||||||||||
Reported operating income (loss) (GAAP basis) | $ | 1,268 | $ | (324 | ) | $ | 4,699 | $ | (10,447 | ) | |||||||
Change in fair value of contingent consideration obligations1 | (283 | ) | 52 | (181 | ) | (90 | ) | ||||||||||
Non-GAAP Operating Income (Loss) | $ | 985 | $ | (272 | ) | $ | 4,518 | $ | (10,537 | ) | |||||||
Non-GAAP Net Income (Loss) | |||||||||||||||||
Reported net income (loss) (GAAP basis) | $ | 1,230 | $ | (481 | ) | $ | 4,159 | $ | (10,276 | ) | |||||||
Change in fair value of contingent consideration obligations1 | (283 | ) | 52 | (181 | ) | (90 | ) | ||||||||||
Non-GAAP Net Income (Loss) | $ | 947 | $ | (429 | ) | $ | 3,978 | $ | (10,366 | ) | |||||||
Non-GAAP Net Income (Loss) Per Diluted Share | |||||||||||||||||
Reported net income (loss) per diluted share (GAAP basis) | $ | 0.05 | $ | (0.02 | ) | $ | 0.18 | $ | (0.50 | ) | |||||||
Change in fair value of contingent consideration obligations1 | (0.01 | ) | — | (0.01 | ) | — | |||||||||||
Non-GAAP Net Income (Loss) Per Diluted Share | $ | 0.04 | $ | (0.02 | ) | $ | 0.17 | $ | (0.50 | ) | |||||||
Weighted average number of diluted shares | 22,970 | 20,869 | 22,989 | 20,704 |
1Results for all periods presented include changes in fair value of contingent consideration obligations associated with the Solar Implant Technology (SIT) acquisition in 2010.
View source version on businesswire.com: http://www.businesswire.com/news/home/20171030005244/en/
Chief Financial Officer
or
Investor Relations
Source: